These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 12756053

  • 21. [Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
    Alvarez Castro AM, Seijo Ríos S, Molina Pérez E, Castroagudín JF, Varo Pérez E.
    Gastroenterol Hepatol; 2012 Nov; 35(9):649-51. PubMed ID: 22749511
    [Abstract] [Full Text] [Related]

  • 22. Belatacept for kidney transplant recipients.
    Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.
    Cochrane Database Syst Rev; 2014 Nov 24; 2014(11):CD010699. PubMed ID: 25416857
    [Abstract] [Full Text] [Related]

  • 23. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP.
    Lancet; 1997 Oct 25; 350(9086):1193-8. PubMed ID: 9652559
    [Abstract] [Full Text] [Related]

  • 24. Langerhans' cell histiocytosis after living donor liver transplantation: report of a case.
    Honda R, Ohno Y, Iwasaki T, Okudaira S, Okada M, Kamitamari A, Ohshima K, Moriuchi H, Kanematsu T.
    Liver Transpl; 2005 Nov 25; 11(11):1435-8. PubMed ID: 16237711
    [Abstract] [Full Text] [Related]

  • 25. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial.
    Neuhaus P, Clavien PA, Kittur D, Salizzoni M, Rimola A, Abeywickrama K, Ortmann E, Chodoff L, Hall M, Korn A, Nashan B, CHIC 304 International Liver Study Group.
    Liver Transpl; 2002 Feb 25; 8(2):132-42. PubMed ID: 11862589
    [Abstract] [Full Text] [Related]

  • 26. Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab.
    Varo E, Lopez A, Castroagudin JF, Delgado M, Conde R, Ferrer E, Otero E, Tomé S, Bustamante M, Rivero C, Martinez J, Mariño A.
    Transplant Proc; 2002 Aug 25; 34(5):1533-4. PubMed ID: 12176471
    [No Abstract] [Full Text] [Related]

  • 27. Experience with basiliximab in pediatric liver graft recipients.
    Ganschow R, Lyons M, Grabhorn E, Venzke A, Broering DC, Rogiers X, Hellwege HH, Burdelski M.
    Transplant Proc; 2001 Aug 25; 33(7-8):3606-7. PubMed ID: 11750532
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
    Yang SL, Wang D, Wu WZ, Lin WH, Xu TZ, Cai JQ, Tan JM.
    Transpl Immunol; 2008 Jan 25; 18(3):281-5. PubMed ID: 18047938
    [Abstract] [Full Text] [Related]

  • 30. A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
    Gruttadauria S, Cintorino D, Piazza T, Mandala L, Doffria E, Musumeci A, Di Trapani G, Arcadipane A, Scianna G, Spada M, Verzaro R, Volpes R, Vizzini G, Palazzo U, Minervini M, Marsh JW, Marcos A, Gridelli B.
    Transplant Proc; 2006 May 25; 38(4):1106-8. PubMed ID: 16757278
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of immunosuppressive regimen on acute rejection and liver graft function.
    Ziolkowski J, Paczek L, Niewczas M, Senatorski G, Oldakowska-Jedynak U, Wyzgal J, Foroncewicz B, Mucha K, Zegarska J, Nyckowski P, Zieniewicz K, Patkowski W, Krawczyk M, Ziarkiewicz-Wroblewska B, Gornicka B.
    Transplant Proc; 2003 Sep 25; 35(6):2281-3. PubMed ID: 14529915
    [Abstract] [Full Text] [Related]

  • 33. Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study.
    Ganschow R, Ericzon BG, Dhawan A, Sharif K, Martzloff ED, Rauer B, Ng J, Lopez P.
    Pediatr Transplant; 2017 Nov 25; 21(7):. PubMed ID: 28714558
    [Abstract] [Full Text] [Related]

  • 34. Initial data on basiliximab in critically ill children undergoing heart transplantation.
    Ford KA, Cale CM, Rees PG, Elliott MJ, Burch M.
    J Heart Lung Transplant; 2005 Sep 25; 24(9):1284-8. PubMed ID: 16143246
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Basiliximab in the therapy of acute rejection after organ transplantation.
    Chariat MN, Erren M, Chariat M, Deng M, Wolters HH, Dietl KH.
    Transplant Proc; 2001 May 25; 33(3):2380. PubMed ID: 11377567
    [No Abstract] [Full Text] [Related]

  • 40. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
    Petz W, Spada M, Bertani A, Lucianctti A, Casagrande F, Guizzetti M, Corno V, Colledan M, Strazzabosco M, Gridelli B.
    Transplant Proc; 2002 Aug 25; 34(5):1966-7. PubMed ID: 12176648
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.